Obesity medicine semaglutide reduces risk of type 2 diabetes: Report
The new obesity medicine semaglutide, which was recently licensed in the US, and has received provisional approval in England, reduces […]
Say something
The new obesity medicine semaglutide, which was recently licensed in the US, and has received provisional approval in England, reduces […]
Post-COVID-19 syndrome (PCS) or Long COVID has emerged as a major roadblock in the recovery of patients infected with SARS-CoV-2. […]
The Ahmedabad-based drug major Zydus Cadila has said that it received approval from the Drug Controller General of India (DCGI) […]
Diabetes has become a disease in public health that is fast approaching epidemic proportions worldwide. It is a disease that […]
With almost 70 million people living with diabetes, India is often referred to as the diabetes capital of the world. […]
Menopause can be a tough time for women. There are so many changes a woman’s body goes through. And if […]
As per a latest study, fat mass index is linked to a higher risk of cardiovascular events in people with […]
It is little surprising to know that in our country where sunshine is available in abundant amount, majority of people […]
Scientists have identified the reason why high blood sugar level makes people prone to cancer. As per a study to […]
As per a recent study, babies born to corpulent mothers are more prone to develop Type-2 diabetes later in their […]
According to a study that is to be published in the ‘Journal of Public Health’ suggested that people who refrain […]
Glenmark Pharma, a Drug major, has launched novel drug Remogliflozin in India, which will be beneficial to treat type-2 diabetes […]
Type 2 diabetes is a major health problem in India and the prence has been escalating in the past few […]